<i>In vitro</i> inhibitory effects of glucosamine, chondroitin and diacerein on human hepatic CYP2D6
Boon Hooi Tan(IMU University), Chin Eng Ong(IMU University), Iekhsan Othman(Monash University Malaysia), Nafees Ahemad(Monash University Malaysia), Uma Devi Palanisamy(Monash University Malaysia), Yan Pan(Zhengzhou University)
Cited by 1
Related Papers
HMGB1: A Common Biomarker and Potential Target for TBI, Neuroinflammation, Epilepsy, and Cognitive Dysfunction
|Frontiers in Neuroscience|2018|318
Current strategies in extending half-lives of therapeutic proteins
|Journal of Controlled Release|2019|285
Impact of HMGB1, RAGE, and TLR4 in Alzheimer’s Disease (AD): From Risk Factors to Therapeutic Targeting
|Cells|2020|257
Mangrove rare actinobacteria: taxonomy, natural compound, and discovery of bioactivity
|Frontiers in Microbiology|2015|178
Enlightening the role of high mobility group box 1 (HMGB1) in inflammation: Updates on receptor signalling
|European Journal of Pharmacology|2019|175